Menu Search
Equities

Insmed Inc

0JAV:LSE

Insmed Inc

Actions
  • Price (USD)72.64
  • Today's Change-0.130 / -0.18%
  • Shares traded773.00
  • 1 Year change+204.42%
  • Beta--
Data delayed at least 20 minutes, as of Nov 08 2024 19:04 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Insmed Inc had net income fall 55.66% from a loss of 481.53m to a larger loss of 749.57m despite a 24.39% increase in revenues from 245.36m to 305.21m.
Gross margin77.25%
Net profit margin-252.01%
Operating margin-240.88%
Return on assets-51.17%
Return on equity-890.75%
Return on investment-59.16%
More ▼

Cash flow in USDView more

In 2023, cash reserves at Insmed Inc fell by 591.66m. Cash Flow from Financing totalled 168.44m or 55.19% of revenues. In addition the company used 536.25m for operations while cash used for investing totalled 223.60m.
Cash flow per share-5.47
Price/Cash flow per share--
Book value per share2.70
Tangible book value per share1.61
More ▼

Balance sheet in USDView more

Insmed Inc has a Debt to Total Capital ratio of 67.02%.
Current ratio6.37
Quick ratio5.99
Total debt/total equity2.03
Total debt/total capital0.6702
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.